• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载药粉末解聚形成微米和亚微米气溶胶的空气动力学因素。

Aerodynamic factors responsible for the deaggregation of carrier-free drug powders to form micrometer and submicrometer aerosols.

机构信息

Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Richmond, Virginia, USA.

出版信息

Pharm Res. 2013 Jun;30(6):1608-27. doi: 10.1007/s11095-013-1001-z. Epub 2013 Mar 8.

DOI:10.1007/s11095-013-1001-z
PMID:23471640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3703624/
Abstract

PURPOSE

To employ in vitro experiments combined with computational fluid dynamics (CFD) analysis to determine which aerodynamic factors were most responsible for deaggregating carrier-free powders to form micrometer and submicrometer aerosols from a capsule-based platform.

METHODS

Eight airflow passages were evaluated for deaggregation of the aerosol including a standard constricted tube, impaction surface, 2D mesh, inward radial jets, and newly proposed 3D grids and rod arrays. CFD simulations were implemented to evaluate existing and new aerodynamic factors for deaggregation and in vitro experiments were used to evaluate performance of each inhaler.

RESULTS

For the carrier-free formulation considered, turbulence was determined to be the primary deaggregation mechanism. A strong quantitative correlation was established between the mass median diameter (MMD) and newly proposed non-dimensional specific dissipation (NDSD) factor, which accounts for turbulent energy, inverse of the turbulent length scale, and exposure time. A 3D rod array design with unidirectional elements maximized NDSD and produced the best deaggregation with MMD<1 μm.

CONCLUSIONS

The new NDSD parameter can be used to develop highly effective dry powder inhalers like the 3D rod array that can efficiently produce submicrometer aerosols for next-generation respiratory drug delivery applications.

摘要

目的

采用体外实验与计算流体动力学(CFD)分析相结合的方法,确定哪些空气动力学因素是从基于胶囊的平台将无载体粉末解聚形成微米和亚微米气溶胶的主要原因。

方法

评估了 8 种气流通道对气溶胶的解聚作用,包括标准收缩管、冲击面、2D 网格、内径向射流以及新提出的 3D 网格和棒阵列。实施了 CFD 模拟以评估用于解聚的现有和新空气动力学因素,并进行了体外实验以评估每个吸入器的性能。

结果

对于所考虑的无载体配方,确定湍流是主要的解聚机制。质量中值直径(MMD)与新提出的无量纲比耗散(NDSD)因子之间建立了很强的定量相关性,该因子考虑了湍流能量、湍流长度尺度的倒数和暴露时间。具有单向元件的 3D 棒阵列设计最大限度地提高了 NDSD,并产生了最佳的解聚作用,MMD<1μm。

结论

新的 NDSD 参数可用于开发高效的干粉吸入器,如 3D 棒阵列,可有效产生亚微米气溶胶,用于下一代呼吸药物输送应用。

相似文献

1
Aerodynamic factors responsible for the deaggregation of carrier-free drug powders to form micrometer and submicrometer aerosols.载药粉末解聚形成微米和亚微米气溶胶的空气动力学因素。
Pharm Res. 2013 Jun;30(6):1608-27. doi: 10.1007/s11095-013-1001-z. Epub 2013 Mar 8.
2
Development and comparison of new high-efficiency dry powder inhalers for carrier-free formulations.开发和比较无载体配方的新型高效干粉吸入器。
J Pharm Sci. 2014 Feb;103(2):465-77. doi: 10.1002/jps.23775. Epub 2013 Dec 4.
3
Development of a New Inhaler for High-Efficiency Dispersion of Spray-Dried Powders Using Computational Fluid Dynamics (CFD) Modeling.利用计算流体动力学(CFD)建模开发高效分散喷雾干燥粉末的新型吸入器。
AAPS J. 2019 Feb 7;21(2):25. doi: 10.1208/s12248-018-0281-y.
4
Tuning aerosol performance using the multibreath Orbital® dry powder inhaler device: controlling delivery parameters and aerosol performance via modification of puck orifice geometry.使用多呼吸Orbital®干粉吸入器装置调节气雾剂性能:通过改变药盘孔口几何形状控制递送参数和气雾剂性能。
J Pharm Sci. 2015 Jul;104(7):2169-76. doi: 10.1002/jps.24458. Epub 2015 Apr 30.
5
Formulating powder-device combinations for salmeterol xinafoate dry powder inhalers.制定沙美特罗氟替卡松干粉吸入器的粉末装置组合。
Int J Pharm. 2015 Jul 25;490(1-2):360-7. doi: 10.1016/j.ijpharm.2015.05.028. Epub 2015 May 15.
6
Particle sizing of pharmaceutical aerosols via direct imaging of particle settling velocities.通过直接测量粒子沉降速度对药物气溶胶进行粒度测定。
Eur J Pharm Sci. 2018 Feb 15;113:152-158. doi: 10.1016/j.ejps.2017.08.016. Epub 2017 Aug 16.
7
Optimizing Aerosolization Using Computational Fluid Dynamics in a Pediatric Air-Jet Dry Powder Inhaler.使用计算流体动力学优化儿科空气射流干粉吸入器的气溶胶化。
AAPS PharmSciTech. 2019 Nov 1;20(8):329. doi: 10.1208/s12249-019-1535-4.
8
Coupled in silico platform: Computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) modelling.耦合的计算平台:计算流体动力学 (CFD) 和基于生理的药代动力学 (PBPK) 建模。
Eur J Pharm Sci. 2018 Feb 15;113:171-184. doi: 10.1016/j.ejps.2017.10.022. Epub 2017 Oct 17.
9
Use of Computational Fluid Dynamics (CFD) Dispersion Parameters in the Development of a New DPI Actuated with Low Air Volumes.利用计算流体动力学(CFD)弥散参数开发一种新的低空气量驱动的干粉吸入器。
Pharm Res. 2019 May 28;36(8):110. doi: 10.1007/s11095-019-2644-1.
10
Development of a high efficiency dry powder inhaler: effects of capsule chamber design and inhaler surface modifications.高效干粉吸入器的研发:胶囊腔室设计及吸入器表面改性的影响
Pharm Res. 2014 Feb;31(2):360-72. doi: 10.1007/s11095-013-1165-6. Epub 2013 Aug 16.

引用本文的文献

1
Characterization of Pediatric Extrathoracic Aerosol Deposition with Air-Jet Dry Powder Inhalers.使用空气喷射干粉吸入器对小儿胸外气溶胶沉积的特征描述
J Aerosol Sci. 2025 Jan;183. doi: 10.1016/j.jaerosci.2024.106474. Epub 2024 Sep 28.
2
Leveraging Numerical Simulation Technology to Advance Drug Preparation: A Comprehensive Review of Application Scenarios and Cases.利用数值模拟技术推进药物制剂:应用场景与案例的全面综述
Pharmaceutics. 2024 Oct 7;16(10):1304. doi: 10.3390/pharmaceutics16101304.
3
Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery.

本文引用的文献

1
Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.干粉吸入制剂的气溶胶化特性增强生长(EEG)应用:喷雾干燥工艺条件对气溶胶性能的影响。
Int J Pharm. 2013 Feb 25;443(1-2):137-45. doi: 10.1016/j.ijpharm.2013.01.003. Epub 2013 Jan 10.
2
In vitro tests for aerosol deposition II: IVIVCs for different dry powder inhalers in normal adults.体外气溶胶沉积测试 II:正常成年人使用不同干粉吸入器的 IVIVC。
J Aerosol Med Pulm Drug Deliv. 2013 Jun;26(3):138-44. doi: 10.1089/jamp.2012.0975. Epub 2012 Sep 4.
3
吸入式纳米颗粒系统:组成、制造和气溶胶传递。
J Aerosol Med Pulm Drug Deliv. 2024 Aug;37(4):202-218. doi: 10.1089/jamp.2024.29117.mk.
4
Quantifying Agglomerate-to-Wall Impaction in Dry Powder Inhalers.定量干粉吸入器中团聚体与壁面的撞击。
Pharm Res. 2023 Jan;40(1):307-319. doi: 10.1007/s11095-022-03446-0. Epub 2022 Dec 5.
5
Near Elimination of In Vitro Predicted Extrathoracic Aerosol Deposition in Children Using a Spray-Dried Antibiotic Formulation and Pediatric Air-Jet DPI.使用喷雾干燥抗生素制剂和儿科空气射流干粉吸入器,近乎消除儿童体外预测的胸腔外气溶胶沉积。
Pharm Res. 2023 May;40(5):1193-1207. doi: 10.1007/s11095-022-03316-9. Epub 2022 Jun 27.
6
Computational Fluid Dynamics (CFD) Guided Spray Drying Recommendations for Improved Aerosol Performance of a Small-Particle Antibiotic Formulation.计算流体动力学 (CFD) 指导喷雾干燥建议,以改善小颗粒抗生素制剂的气溶胶性能。
Pharm Res. 2022 Feb;39(2):295-316. doi: 10.1007/s11095-022-03180-7. Epub 2022 Feb 11.
7
Comparative Assessment of In Vitro and In Silico Methods for Aerodynamic Characterization of Powders for Inhalation.吸入用粉末空气动力学特性的体外和计算机模拟方法的比较评估
Pharmaceutics. 2021 Nov 2;13(11):1831. doi: 10.3390/pharmaceutics13111831.
8
Design and Comprehensive Characterization of Tetramethylpyrazine (TMP) for Targeted Lung Delivery as Inhalation Aerosols in Pulmonary Hypertension (PH): In Vitro Human Lung Cell Culture and In Vivo Efficacy.用于肺动脉高压(PH)吸入气雾剂靶向肺部递送的川芎嗪(TMP)的设计与综合表征:体外人肺细胞培养和体内疗效
Antioxidants (Basel). 2021 Mar 11;10(3):427. doi: 10.3390/antiox10030427.
9
High-Efficiency Dry Powder Aerosol Delivery to Children: Review and Application of New Technologies.向儿童高效递送干粉气雾剂:新技术综述与应用
J Aerosol Sci. 2021 Mar;153. doi: 10.1016/j.jaerosci.2020.105692. Epub 2020 Oct 14.
10
Flow and Particle Modelling of Dry Powder Inhalers: Methodologies, Recent Development and Emerging Applications.干粉吸入器的流动与颗粒建模:方法、最新进展及新兴应用
Pharmaceutics. 2021 Feb 1;13(2):189. doi: 10.3390/pharmaceutics13020189.
Condensational growth of combination drug-excipient submicrometer particles for targeted high-efficiency pulmonary delivery: evaluation of formulation and delivery device.
组合药物-赋形剂亚微米颗粒的冷凝生长用于靶向高效肺部递药:制剂和递药装置的评价。
J Pharm Pharmacol. 2012 Sep;64(9):1254-63. doi: 10.1111/j.2042-7158.2012.01476.x. Epub 2012 Feb 21.
4
Performance of combination drug and hygroscopic excipient submicrometer particles from a softmist inhaler in a characteristic model of the airways.软雾吸入器中组合药物和吸湿性赋形剂亚微米颗粒在气道特征模型中的性能。
Ann Biomed Eng. 2012 Dec;40(12):2596-610. doi: 10.1007/s10439-012-0616-2. Epub 2012 Jul 21.
5
Effect of device design on the in vitro performance and comparability for capsule-based dry powder inhalers.装置设计对基于胶囊的干粉吸入器的体外性能和可比性的影响。
AAPS J. 2012 Dec;14(4):667-76. doi: 10.1208/s12248-012-9379-9. Epub 2012 Jun 22.
6
Comparing MDI and DPI aerosol deposition using in vitro experiments and a new stochastic individual path (SIP) model of the conducting airways.比较 MDI 和 DPI 气溶胶沉积的体外实验和新的传导气道随机个体路径(SIP)模型。
Pharm Res. 2012 Jun;29(6):1670-88. doi: 10.1007/s11095-012-0691-y.
7
Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery--a review for multidisciplinary researchers.开发高效可靠的肺部药物传递干粉吸入器——多学科研究人员的综述。
Med Eng Phys. 2012 May;34(4):409-27. doi: 10.1016/j.medengphy.2011.12.025. Epub 2012 Jan 23.
8
Dry powder inhaler device influence on carrier particle performance.干粉吸入器装置对载体颗粒性能的影响。
J Pharm Sci. 2012 Mar;101(3):1097-107. doi: 10.1002/jps.22824. Epub 2011 Nov 17.
9
The use of computational approaches in inhaler development.计算方法在吸入器开发中的应用。
Adv Drug Deliv Rev. 2012 Mar 30;64(4):312-22. doi: 10.1016/j.addr.2011.10.004. Epub 2011 Oct 23.
10
Condensational growth of combination drug-excipient submicrometer particles for targeted high efficiency pulmonary delivery: comparison of CFD predictions with experimental results.载药辅料亚微米粒子的冷凝生长用于靶向高效肺部递药:CFD 预测与实验结果的比较。
Pharm Res. 2012 Mar;29(3):707-21. doi: 10.1007/s11095-011-0596-1. Epub 2011 Sep 27.